Young Kwang Chae


Dr. Young Kwang Chae is the co-director of the Early Phase Clinical Trials Units of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He is also the co-director of the Developmental Therapeutics Fellowship program of the division of hematology-oncology at the Northwestern University Feinberg School of Medicine. His primary focus is on designing and conducting innovative early-phase clinical trials and translational medicine research. Dr. Chae is in charge of many targeted therapy clinical trials, immunotherapy combination trials, and biomarker studies within and outside Northwestern University. He is one of the study chairs and translational medicine PI of the SWOG S1609 DART trial for rare tumors. He is also an active member of the SWOG lung committee and the vice chair of the early therapeutics & rare cancer committee and lung committee. He believes that his clinic is his lab and wants to bridge the gap between cutting-edge science and clinical medicine. Above all, his passion is to help desperate patients including those with rare cancers who do not have standard-of-care treatment options or have become refractory to all existing treatment options with novel treatments through well-designed clinical trials bringing the best science to patients. Dr. Chae plans to facilitate the incorporation of novel translational science into high-impact clinical trials.